Filing Details

Accession Number:
0001209191-13-015120
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-03-08 06:49:35
Reporting Period:
2013-03-07
Filing Date:
2013-03-08
Filing Date Changed:
2013-03-08
Accepted Time:
2013-03-08 06:49:35
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
944809 Opko Health, Inc. OPK Pharmaceutical Preparations (2834) 752402409
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
898860 Al Et Md Phillip Frost Opko Health, Inc.
4400 Biscayne Blvd.
Miami FL 33137
Ceo & Chairman Yes Yes Yes No
1380896 Trust Investments Gamma Frost 4400 Biscayne Blvd.
Miami FL 33137
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Acquisiton 2013-03-07 1,600 $7.29 121,257,854
Common Stock Acquisiton 2013-03-07 1,500 $7.29 121,259,354
Common Stock Acquisiton 2013-03-07 700 $7.30 121,260,054
Common Stock Acquisiton 2013-03-07 3,100 $7.31 121,263,154
Common Stock Acquisiton 2013-03-07 1,200 $7.32 121,264,354
Common Stock Acquisiton 2013-03-07 2,900 $7.34 121,267,254
Common Stock Acquisiton 2013-03-07 8,300 $7.34 121,275,554
Common Stock Acquisiton 2013-03-07 2,900 $7.35 121,278,454
Common Stock Acquisiton 2013-03-07 19,063 $7.36 121,297,517
Common Stock Acquisiton 2013-03-07 237 $7.37 121,297,754
Common Stock Acquisiton 2013-03-07 4,400 $7.39 121,302,154
Common Stock Acquisiton 2013-03-07 600 $7.40 121,302,754
Common Stock Acquisiton 2013-03-07 600 $7.42 121,303,354
Common Stock Acquisiton 2013-03-07 4,400 $7.43 121,307,754
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 15,490,546 Indirect See Footnote
Footnotes
  1. The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  2. These securities are owned directly by The Frost Group, LLC. Frost Gamma Investments Trust is a principal member of The Frost Group, LLC. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Billionaire Hedge Funds
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!